. Author manuscript; available in PMC: 2008 Nov 16.

Published in final edited form as: Arch Ophthalmol. 2006 Mar;124(3):345–352. doi: 10.1001/archopht.124.3.345

Table 2.

Patient Data at Baseline and Follow-up

Patient/Sex/Age, y	Follow-up, mo	Eye	Baseline Visual Acuity	Follow-up Visual Acuity	Drusen
1/F/71	41	OD	20/20	20/20	Increase
5/F/76	33	OS	20/16	20/20	Decrease, RPE changes
6/F/77	33	OS	20/16	20/25	No change
8/F/70	29	OD	20/20	20/20	No change
9/F/77	29	OD	20/16	20/25	No change
10/F/72	29	OS	20/25	20/25	No change
12/F/86	29	OS	20/32	20/40	Decrease, RPE changes
13/F/74	28	OD	20/25	20/20	No change
	28	OS	20/20	20/20	Increase
14/M/87	29	OS	20/40	20/32	No change
15/F/73	28	OD	20/25	20/20	Increase
	28	OS	20/25	20/32	Increase
16/F/61	28	OD	20/20	20/20	Decrease, RPE changes
17/M/70	29	OD	20/40	20/40	No change
	29	OS	20/32	20/32	Increase
18/F/80	41	OS	20/32	20/25	No change
19/F/78	40	OS	20/20	20/16	Increase

Abbreviations: OD, right eye; OS, left eye; RPE, retinal pigment epithelium.